Records containing: Hematologic Malignancies
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-28DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
-
CLINICAL_TRIALS study record update · 2026-01-28Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor-T Cell (CAR-T)Therapy
-
CLINICAL_TRIALS study record update · 2026-01-23Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2026-01-16An Expanded Access Program for Orca-T Products That Are Out of Specification for Commercial Release
-
CLINICAL_TRIALS study record update · 2026-01-14Follow-Up Evaluation for Gene-Therapy Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-06LCCC 1229: Developing a Prospective Lymphoma Clinical Cohort in Malawi
-
CLINICAL_TRIALS study record update · 2026-01-05An Exploratory Clinical Study of the Safety and Efficacy of Allogenic CD19-Targeted Chimeric Antigen Receptor T-Cell Injection in the Treatment of Relapsed/Refractory B-Cell Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-12-10An Open-Label, Multicenter, Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
-
CLINICAL_TRIALS study record update · 2025-12-05IIT2022-03-Paquette-GeriBMT: A Phase I Study of De-Escalation of Post-Transplant Cyclophosphamide Dosing in Patients Aged >/= 65 Years Undergoing Conditioning With Fludarabine and Total Body Irradiation 800 cGy
-
CLINICAL_TRIALS study record update · 2025-12-04Optimized CBT for Pts With High-risk Hematologic Malignancies Who Have Relapsed After First ASCT
-
CLINICAL_TRIALS study record update · 2025-12-01A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics Characteristics and Preliminary Efficacy of BL-M24D1 for Injection in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-12-01Gene Therapy Follow up Protocol for Subjects Previously Enrolled in CAR T-Cell Studies
-
CLINICAL_TRIALS study record update · 2025-11-21A Phase II/III Study of ICP-248 in Combination With Orelabrutinib in Patients With Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
CLINICAL_TRIALS study record update · 2025-11-20A Compassionate Release Protocol: Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Allogeneic Transplantation Using a Related Haplo-Identical Donor and Unrelated, Umbilical Cord Blood Donor(s) for the Treatment of High Risk Malignancies or Non-Malignant Disorders Requiring Allogeneic Transplantation
-
CLINICAL_TRIALS study record update · 2025-11-18Efficacy and Safety of Protein A Immunoadsorption-Based Desensitization in Highly Sensitized Haploidentical Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study
-
CLINICAL_TRIALS study record update · 2025-11-10A Phase 2 Study of Nonmyeloablative Conditioning With Transplantation of Partially Human Leukocyte Antigen (HLA)-Mismatched Bone Marrow and Post-transplant Cyclophosphamide for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-10-21GRAVITAS-119: A Single-Arm, Open-Label, Phase 1 Study of Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
-
CLINICAL_TRIALS study record update · 2025-09-26An Open-Label, Multi-Center, Phase I Study to Evaluate the Safety, Tolerability，Pharmacokinetic/Pharmacodynamics and Anti-tumor Activity of Tetra-specific Antibody GNC-035 in Participants With Relapsed/Refractory Hematologic Malignancy and Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-08-12A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
-
CLINICAL_TRIALS study record update · 2025-07-04A Phase II Trial of Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
-
CLINICAL_TRIALS study record update · 2025-06-29A Pilot Study of Condensed Busulfan, Melphalan, and Fludarabine Conditioning Prior to Ex-vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2025-05-28Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic Cells (Haplo-HCT) For Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-04-13Long Term Follow up Study for Participants Treated With an Allogeneic CAR T-Cell Product in a Prior Clinical Study
-
CLINICAL_TRIALS study record update · 2025-04-08Phase 1/2 Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2025-02-19BT13BTθ51 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation with Alpha Beta T Cell and B Cell Depletion for Patients with Hematologic Malignancies